Formulation of dacarbazine-loaded cubosomes. Part III. Physicochemical characterization.
about
Nanotechnology-Based Drug Delivery Systems for Melanoma Antitumoral Therapy: A ReviewIn vitro and in vivo evaluation of cubosomes containing 5-fluorouracil for liver targeting.Engineering nanomedicines for improved melanoma therapy: progress and promises.Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier.Potential combination topical therapy of anal fissure: development, evaluation, and clinical study†
P2860
Formulation of dacarbazine-loaded cubosomes. Part III. Physicochemical characterization.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Formulation of dacarbazine-loaded cubosomes. Part III. Physicochemical characterization.
@ast
Formulation of dacarbazine-loaded cubosomes. Part III. Physicochemical characterization.
@en
Formulation of dacarbazine-loaded cubosomes. Part III. Physicochemical characterization.
@nl
type
label
Formulation of dacarbazine-loaded cubosomes. Part III. Physicochemical characterization.
@ast
Formulation of dacarbazine-loaded cubosomes. Part III. Physicochemical characterization.
@en
Formulation of dacarbazine-loaded cubosomes. Part III. Physicochemical characterization.
@nl
prefLabel
Formulation of dacarbazine-loaded cubosomes. Part III. Physicochemical characterization.
@ast
Formulation of dacarbazine-loaded cubosomes. Part III. Physicochemical characterization.
@en
Formulation of dacarbazine-loaded cubosomes. Part III. Physicochemical characterization.
@nl
P2093
P2860
P1433
P1476
Formulation of dacarbazine-loaded cubosomes. Part III. Physicochemical characterization
@en
P2093
Bi-Botti C Youan
P2860
P2888
P304
P356
10.1208/S12249-010-9496-7
P407
P577
2010-08-06T00:00:00Z
P5875
P6179
1044439313